Hint mode is switched on Switch off
For swift navigation between sections

CytoMed Therapeutics
LEI 984500AB7AC14B9EE823

Organization name
CytoMed Therapeutics Limited
Country name
Singapore
Country of registration
Singapore
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Cytomed Therapeutics Limited operates as a pre-clinical biopharmaceutical company. The Company focuses on developing novel cell-based immunotherapies for treatment of human cancers. CytoMed Therapeutics serves customers in Singapore.

Awards

Documentation

IFRS/US GAAP reports

2025
2024
2023
2022
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • LEI
    984500AB7AC14B9EE823
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001873093
  • UEN
    201808327H
Registration is required to get access.